Electronic Gazette
Invention Granted Under R.A. 8293 (PCT)
Volume Number: VOL 10 NO 27
Date Released: 8/13/2007

[11] Number:1 -2003-500145Document Code: PH B1
[45] Issued:6/28/2007
[54] Title:NOVEL NON-IMIDAZOLE COMPOUNDS
[72] Inventor(s): NENG-YANG SHIH, OF NEW JERSEY, UNITED STATES OF AMERICA
CHRISTOPHER W BOYCE, OF NEW JERSEY, UNITED STATES OF AMERICA
MWANGI WA MUTAHI, OF NEW JERSEY, UNITED STATES OF AMERICA
JOHN J PIWINSKI, OF NEW JERSEY, UNITED STATES OF AMERICA
ROBERT G ASLANIAN, OF NEW JERSEY, UNITED STATES OF AMERICA
MICHAEL Y BERLIN, OF NEW JERSEY, UNITED STATES OF AMERICA
PIETRO MANGIARACINA, OF NEW YORK, UNITED STATES OF AMERICA
PAULINE C TING, OF NEW JERSEY, UNITED STATES OF AMERICA
STUART B ROSENBLUM, OF NEW JERSEY, UNITED STATES OF AMERICA
KEVIN D McCORMICK, OF NEW JERSEY, UNITED STATES OF AMERICA
WING C TOM, OF NEW JERSEY, UNITED STATES OF AMERICA
[73] Applicant/Assignee(s): SCHERING CORPORATION , OF NEW JERSEY, UNITED STATES OF AMERICA
[74] Attorney/Agent:SIGUION REYNA ET AL
[22] Date Filed:3/19/2003
[21] Application Serial Number:1- 2003-500145
[30]  Priority Data:
 
NumberDateCountry
60/240,90110/17/2000 UNITED STATES OF AMERICA

[52] PH Class: NONE
[51] International Class7: A61K 31/4545;  A61K 31/506;  A61P 3/04;  C07D 213/73;  C07D 401/12;  C07D 409/14;  C07D 413/14;  C07D 417/14;  C07D 498/04;  A61K 31/4985;  A61K 31/4523;  C07D 401/14;  A61P 37/08
[58] Field of Search: A61K 31/4545;  A61K 31/506;  A61P 3/04;  C07D 213/73;  C07D 401/12;  C07D 409/14;  C07D 413/14;  C07D 417/14;  C07D 498/04;  A61K 31/4985;  A61K 31/4523;  C07D 401/14;  A61P 37/08
[56] Reference(s) Cited and/or Considered: NONE 
[57] Abstract:

Disclosed are novel compounds of the formula: (I) Also disclosed are pharmaceutical compositions comprising the compounds of Formula (I). Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula (I). Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e,g., nasal congestion) using the compounds of Formula (I) in combination with a H1 receptor antagonist.

No. of Claims: 246